The Cardiac Genetics Clinic: a model for multidisciplinary genomic medicine

Dominica Zentner1, Tina N Thompson2, Paul A James2

  • 1Royal Melbourne Hospital, Melbourne, VIC dominica.zentner@mh.org.au.

Insights

Genetic testing for cardiac conditions identified pathogenic mutations in 15.3% of patients at a specialized clinic. The Cardiac Genetics Clinic (CGC) provides crucial diagnostic and risk management services for inherited cardiac diseases.

Area of Science:

  • Cardiovascular Medicine
  • Medical Genetics
  • Clinical Diagnostics

Background:

  • Multidisciplinary Cardiac Genetics Clinics (CGC) are essential for diagnosing and managing inherited cardiac conditions.
  • Understanding patient demographics and the utility of genetic testing is crucial for service optimization.

Purpose of the Study:

  • To characterize patient profiles, clinical procedures, and genetic testing uptake at the Royal Melbourne Hospital's CGC over its initial six years.
  • To evaluate the diagnostic yield of genetic testing in a diverse cohort with inherited cardiac diseases.

Main Methods:

  • A retrospective database review of 1170 individuals attending the CGC between July 2007 and July 2013.
  • Patients were categorized by cardiac diagnosis, and data on clinic visits and genetic testing incidence were analyzed.

Main Results:

  • 32.6% of individuals (381/1170) underwent genetic testing, with pathogenic mutations identified in 47.6% of these tests.
  • The most common diagnostic categories were cardiomyopathy, aortopathy, arrhythmia disorders, and sudden cardiac death/family history.
  • A pathogenic mutation was identified in 15.3% of the total patient population.

Conclusions:

  • The CGC plays a vital role in diagnosing and managing patients with genetic cardiac conditions.
  • Clinical practice evolved from candidate gene testing to broader next-generation sequencing panels, potentially increasing mutation detection.
  • The clinic provides essential diagnostic clarity and risk management plans for individuals and families affected by inherited cardiac diseases.
Abstract

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
647
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
151
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K